HEPATIC CELL CARCINOMA
Clinical trials for HEPATIC CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HEPATIC CELL CARCINOMA trials appear
Sign up with your email to follow new studies for HEPATIC CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy tested for Tough-to-Treat liver cancers
Disease control Recruiting nowThis is an early-stage safety study testing a new type of immune cell therapy called HRYZ-T102. It is for adults with advanced liver cancer or other solid tumors that have stopped responding to standard treatments and who have a specific genetic marker (HLA-A 02:03). Researchers …
Matched conditions: HEPATIC CELL CARCINOMA
Phase: PHASE1 • Sponsor: Shanghai Ruiliyuan Biotechnology Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Revolutionary One-Stop scan could transform liver disease monitoring
Diagnosis Recruiting nowThis study is testing a new type of medical scan that combines two imaging techniques (PET and MRI) into one session. The goal is to see if this 'one-stop' scan can give doctors a clearer, more complete picture of liver damage, scarring (fibrosis), and cancer risk in people with …
Matched conditions: HEPATIC CELL CARCINOMA
Sponsor: Massachusetts General Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC